WA-MARY-KAY
2.6.2022 22:55:07 CEST | Business Wire | Press release
Calling all models—your virtual runway awaits! Step & Repeat, the first ever style and fashion competition launched on TikTok, returns for season two on June 7. Last year, Glamhive and Mary Kay Global Design Studio unveiled the fashion reality contest that reached millions of users worldwide. Now, the four-week style challenge is back and promises to be the fashion extravaganza we’ve all been waiting for.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220602005868/en/
Celebrity Stylist Zadrian Smith (clients include: Ariana DeBose, Naama Preis, Naomi Scott) hosts Step & Repeat with three judges and industry favorites: celebrity stylist Tara Swennen (clients include: Kristen Stewart, Matthew McConaughey), celebrity stylist Nicole Chavez (clients include: Kristen Bell, Jessica Simpson), and celebrity hairstylist Larry Sims (clients include: Victoria Beckham, Queen Latifah).
Each week, host Zadrian Smith will announce a theme-based challenge for TikTok users to showcase their creativity through wardrobe, makeup, and hair. The show’s celebrity judges will duet the best looks from around the world and cast their votes for winners in each category. Participants are asked to incorporate the show’s custom sound, “Step & Repeat,” and hashtags, #stepandrepeat, #glamhive, and #marykay to enter their video into the competition. For each challenge there will be three winners, hand-picked by the judges, who will receive a cash prize plus an hour one-on-one meeting with an industry mentor.
At the end of the four weeks, Step & Repeat will announce one overall winner for each category, crowning them the very best in wardrobe, makeup, and hair based on entries from all over the world. TikTok is the place for anyone with talent and a creative voice to share their gift on a global scale. Step & Repeat is the platform that gives you the opportunity to be seen and celebrated.
Zadrian Smith, Celebrity Stylist (Host)
“As my career has progressed as a Global Fashion Director and Journalist, I’ve wanted to prioritize working to create a more equitable fashion industry. It’s not always easy or comfortable work, but any opportunity that I can provide to help other people interested in the industry with a step up - that’s a conversation that I want to be a part of.”
Tara Swennen, Celebrity Stylist (Judge)
“There are so many people with incredible creative talent and Step & Repeat gives them a place to shine. I'm very excited to see the looks that people from all over the world will be debuting on our social media runway!”
Nicole Chavez, Celebrity Stylist (Judge)
“Season One of ‘Step & Repeat’ absolutely inspired me. I was excited every week to see what the contestants created and blown away by the range of talent. I can't wait to see the results of our challenges in Season Two!”
Larry Sims, Celebrity Hairstylist (Judge)
“It takes courage, confidence, & creativity to show the world why you're an amazing artist. I’m excited to see the contestants bring it!”
Stephanie Sprangers, Founder and CEO of Glamhive
“Our vision for ‘Step & Repeat’ was to create a fast-paced style competition that encompassed creativity, inclusivity, connections, and recognition, and Season One delivered in spades. Now, for the second time, the industry's best are coming together to welcome and encourage style talent from around the world. We're so excited to see what happens in Season Two.”
Step & Repeat Mentors:
- Claire Sulmers, CEO & Founder of Fashion Bomb Daily
- Adam Drawas, Owner, Walker Drawas PR
- Quentin Thrash, Bespoke Designer & Celebrity Barber
- Brian Underwood, Fashion Director, Women’s Health
- Mandi Line, Costume Designer (The Bold Type, Pretty Little Liars, Shameless)
- Pandora Amoratis, Style Director, US Daily Mail
- Sheridan Ward, Celebrity Hairstylist
- Shatora Adrell, Fashion Designer and Stylist
- Carrie Colbert, Founding & General Partner, Curate Capital
- Quinn Murphy, Celebrity Makeup Artist
- Alexis Bennett, Editor, Vogue
- Gilda Koral Flora, Founder, Koral Communications
- Christian Wood, Celebrity Hairstylist
For more information, visit https://www.glamhive.com/tiktok
About Glamhive: Glamhive was founded by entrepreneur Stephanie Sprangers in 2017 with the vision to democratize personal styling and the premise that the confidence that comes with glamour should not be exclusive to the rich and famous. The online styling experience offers anyone with a WiFi connection access to stylists who will provide them with the support they need to be the best version of themselves. For stylists, it is a seamless end-to-end platform to help them grow their network and their business, 100% virtually.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com , find us on Facebook , Instagram , and LinkedIn , or follow us on Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005868/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release
If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release
This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release
New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 14:41:00 CET | Press release
Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom